Galunhui October 15th | chengdu kanghua biological products (300841.SZ) stated at an investor relations event that the sales price of the company's diploid cell rabies vaccine is mainly determined by the company based on production costs, product positioning, target area consumption levels, and other factors. The bidding price is determined in advance and finally confirmed through the bidding process or selection process of provincial CDCs in various regions. The average sales price of the company's diploid cell rabies vaccine has slightly increased since its listing, and currently the sales price for a single vaccine injection is around 300 RMB.
康华生物(300841.SZ)：公司人二倍体细胞狂犬病疫苗自上市以来销售均价略有上涨
chengdu kanghua biological products (300841.SZ): Since its launch, the company's diploid cell rabies vaccine has experienced a slight increase in average selling price.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha
【November 2024】Has disney's predicament turned around? Pay attention to these 3 performance signals.
As the entertainment kingdom for nearly a century, Disney's status in Hollywood has gained prominence. Over 60 years of listing on the U.S. stock market, Disney